These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12691213)

  • 21. Impulsivity, risk taking and recreational 'ecstasy' (MDMA) use.
    Butler GK; Montgomery AM
    Drug Alcohol Depend; 2004 Oct; 76(1):55-62. PubMed ID: 15380289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ecstasy (MDMA) exposure and neuropsychological functioning: a polydrug perspective.
    Medina KL; Shear PK; Corcoran K
    J Int Neuropsychol Soc; 2005 Oct; 11(6):753-65. PubMed ID: 16248911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of acute psychotic episode after a single dose of ecstasy].
    Vaiva G; Bailly D; Boss V; Thomas P; Lestavel P; Goudemand M
    Encephale; 2001; 27(2):198-202. PubMed ID: 11407274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia.
    White B; Day C; Degenhardt L; Kinner S; Fry C; Bruno R; Johnston J
    Drug Alcohol Depend; 2006 Jul; 83(3):210-7. PubMed ID: 16343810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with driving under the influence of alcohol and drugs among an Australian sample of regular ecstasy users.
    Matthews A; Bruno R; Johnston J; Black E; Degenhardt L; Dunn M
    Drug Alcohol Depend; 2009 Feb; 100(1-2):24-31. PubMed ID: 19013726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathways into ecstasy use: the role of prior cannabis use and ecstasy availability.
    Zimmermann P; Wittchen HU; Waszak F; Nocon A; Höfler M; Lieb R
    Drug Alcohol Depend; 2005 Sep; 79(3):331-41. PubMed ID: 15913921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An investigation of factors associated with depressive symptoms among a sample of regular ecstasy consumers.
    Matthews AJ; Bruno R
    Neuropsychobiology; 2010; 61(4):215-22. PubMed ID: 20389132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ecstasy use and suicidal behavior among adolescents: findings from a national survey.
    Kim J; Fan B; Liu X; Kerner N; Wu P
    Suicide Life Threat Behav; 2011 Aug; 41(4):435-44. PubMed ID: 21631573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Past 12-month and lifetime comorbidity and poly-drug use of ecstasy users among young adults in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Keyes KM; Martins SS; Hasin DS
    Drug Alcohol Depend; 2008 Sep; 97(1-2):139-49. PubMed ID: 18524499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.
    Scholey AB; Parrott AC; Buchanan T; Heffernan TM; Ling J; Rodgers J
    Addict Behav; 2004 Jun; 29(4):743-52. PubMed ID: 15135556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The health effects of ecstasy: a literature review.
    Gowing LR; Henry-Edwards SM; Irvine RJ; Ali RL
    Drug Alcohol Rev; 2002 Mar; 21(1):53-63. PubMed ID: 12189005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.
    Gouzoulis-Mayfrank E; Thimm B; Rezk M; Hensen G; Daumann J
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):819-27. PubMed ID: 12921915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sources of information about MDMA (3,4-methylenedioxymethamphetamine): perceived accuracy, importance, and implications for prevention among young adult users.
    Falck RS; Carlson RG; Wang J; Siegal HA
    Drug Alcohol Depend; 2004 Apr; 74(1):45-54. PubMed ID: 15072806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with Ecstasy use in Turkish students.
    Corapçioğlu A; Ogel K
    Addiction; 2004 Jan; 99(1):67-76. PubMed ID: 14678064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy.
    Sumnall HR; Cole JC; Jerome L
    J Psychopharmacol; 2006 Sep; 20(5):670-82. PubMed ID: 16401654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coping style and ecstasy use motives as predictors of current mood symptoms in ecstasy users.
    Scott RM; Hides L; Allen JS; Lubman DI
    Addict Behav; 2013 Oct; 38(10):2465-72. PubMed ID: 23770644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective associations between meth/amphetamine (speed) and MDMA (ecstasy) use and depressive symptoms in secondary school students.
    Brière FN; Fallu JS; Janosz M; Pagani LS
    J Epidemiol Community Health; 2012 Nov; 66(11):990-4. PubMed ID: 22516739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is ecstasy perceived to be safe? A critical survey.
    Gamma A; Jerome L; Liechti ME; Sumnall HR
    Drug Alcohol Depend; 2005 Feb; 77(2):185-93. PubMed ID: 15664720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Illicit drugs use in Georgian students; pilot study rigorously following criteria of European School Project on Alcohol and Other Drug.
    Gamkrelidze A; Baramidze L; Sturua L; Galdava G
    Georgian Med News; 2010 Mar; (180):39-46. PubMed ID: 20413816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Club drug use in Germany.
    Soellner R
    Subst Use Misuse; 2005; 40(9-10):1279-93. PubMed ID: 16048817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.